Last update 11 Jul 2024

RLYB-116

Overview

Basic Info

Drug Type
Biological products
Synonyms
Target
Mechanism
C5 inhibitors(Complement C5 inhibitors)
Inactive Indication
Originator Organization
Active Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hemoglobinuria, ParoxysmalPhase 1
US
30 Jan 2022
Myasthenia GravisPhase 1
US
30 Jan 2022
InflammationPhase 1
SE
31 Dec 2013
Autoimmune DiseasesPreclinical
SE
31 Dec 2013
Autoimmune DiseasesPreclinical
SE
31 Dec 2013
InflammationPreclinical
SE
31 Dec 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Biospace
ManualManual
Phase 1
-
12
(kekprovzhn) = covmfkadda pbqnkvspom (iwywgpxnyp )
Positive
20 Dec 2023
(100 mg)
(ehkvfkpwjw) = zmtlyjdkue ibxtzebdbb (rsgeuibcey )
Phase 1
-
6
(voqtngwjxj) = Subcutaneously administered RLYB116 was observed to be generally well-tolerated at the 100 mg dose, with mild or moderate adverse events and no drug-related serious adverse events reported. brobydokme (oajwrwyttl )
Positive
07 Nov 2022
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free